Interns continue to make tough choices

Published Date: 02 Mar 2023

The Medscape Ethics Survey investigated how internal medicine physicians view the ethical aspects of the response to medical assistance in dying, gender-related publications and materials.

Read Full News

Latest News

Optimizing DPYD Testing Prior to Fluoropyrimidine Therapy

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

Syngeneic Modeling of Diet-Driven Liver Cancer

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

VA Dashboards for Clinical Pathway & Genetic Testing Use

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Melanoma Clinical Pearls: 5 Core Principles

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Q&A: Melanoma Clinical Guidance

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

Woman’s 3-Year Lip Swelling Reveals Granulomatous Cheilitis

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

Todays Updates

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.

Todays Updates

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.

Latest News

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

News All Time

A Woman on Ruxolitinib Had TB That Mimicked Metastases

A woman receiving ruxolitinib for polycythemia vera developed disseminated tuberculosis despite a negative IGRA, highlighting the limits of screening.

Pediatric Gastroenterology Faces AI Reality Check

From nutrition screening to IBD monitoring, AI shows promise in pediatric gastroenterology — yet experts stress pediatric validation is essential.

Hidradenitis Suppurativa–Associated Squamous Cell Carcinoma

Four cases highlight the aggressive nature of cutaneous squamous cell carcinoma arising in chronic perianal and gluteal hidradenitis suppurativa.

FDA Neurology Digest: August 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of neurologic conditions.

Sentinel Lymph Node Biopsy De-Implementation in Women Veterans

This study sought to quantify low-value sentinel lymph node biopsy practices among populations eligible for a de-escalated surgical approach in VA.

Expanding Access to Pediatric Dermatology Through Store-and-Forward Teledermatology

A pediatric dermatology–specific store-and-forward service can enhance access to specialty expertise, support care coordination, and integrate into clinical practice without increasing consultant workload.

Informed-Consent Gaps in Prostate Cancer Genetic Testing

Are oncologists missing key details during genetic testing consent? Dr Maurie Markman reviews new data and why current informed consent falls short.

Kratom: An Emerging Cause of Drug-Induced Hyperpigmentation

Kratom is an increasingly common environmental exposure with potential dermatologic consequences. Learn to recognize its association with hyperpigmentation.

Rethinking Laboratory Screening for Patients Receiving Biologics

Do all patients on biologics need routine laboratory screening? A risk-based approach can help clinicians determine when testing is truly worthwhile.

CCND1-Negative Mantle Cell Lymphoma With Balanced CCND3-IGH Rearrangement: Case Report and Literature Review

CCND1-Negative Mantle Cell Lymphoma With Balanced CCND3-IGH Rearrangement: Case Report and Literature Review

Development of a National Hematology Program: Advancing Classical Hematology Care for Veterans

Many classical (nonmalignant) hematologic disorders—including venous thromboembolism (VTE), sickle cell trait, bleeding or clotting disorders, G6PD deficiency, and others—have a propensity to manifest under physical stress or trauma.

Solitary Tender Nodule on the Forearm

A 36-year-old woman presented to the dermatology department with a nodule on the left forearm. What’s your diagnosis?

S1 Episode 4: How Early Is Early Enough to Reverse MASLD?

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

Teen With a Slowly Enlarging Annular Hyperkeratotic Papule

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

ArteraAI: Current Indications in Prostate Cancer

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

Thyroid Surgery: Practical Strategies for Optimal Post-op Care

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

Recommended News For You

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

Lymph node transfer reduces arm swelling after breast cancer surgery, study shows

Breast density changes over time are associated with an increased risk of cancer.

3D Mammography Improves Long-Term Cancer Risk Prediction

Psychiatric Disorders Are Common in Dementia Patients.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Recommended Articles For You

HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer 

Red Cell Adaptation During Female Reproductive Transitions: Mechanisms, Clinical Implications, and Evidence-Based Insights 

Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec 

Emerging Trends in Oncology and Precision Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

2.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

3.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

4.

A Sinister Etiology for Shoulder Pain

5.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

1.

Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics

2.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

3.

Cancer Staging Education Through Interactive Anatomical Spread Maps

4.

Modern Developments in Oncology for Specialists

5.

Breaking Barriers: Innovative Approaches in Brain Tumor Treatment

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

Understanding the Common Causes of Anemia

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

4.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

5.

Should We Use DARA Up Front As First-Line Therapy in MM?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot